Table 1. Correlation between Clinicopathologic Features and Serum CXCL3 Protein Expression.
| CXCL3 |
p Value | |||
|---|---|---|---|---|
| Low | High | |||
| Count | Count | |||
| Gender | Male | 35 (74.47%) | 58 (74.36%) | 0.989 |
| Female | 12 (25.53%) | 20 (25.64%) | ||
| Age | <50 | 21 (44.68%) | 36 (46.15%) | 0.873 |
| >50 | 26 (55.32%) | 42 (53.85%) | ||
| AFP | <200 pg/ml | 29 (65.91%) | 50 (64.10%) | 0.841 |
| >200 pg/ml | 15 (34.09%) | 28 (35.90%) | ||
| Intrahepaticmetastasis | No | 30 (63.83%) | 55 (70.51%) | 0.438 |
| Yes | 17 (36.17%) | 23 (29.49%) | ||
| Vascular Invasion | No | 40 (100%) | 68 (90.67%) | 0.046a* |
| Yes | 0 (0%) | 7 (9.33%) | ||
| Capsule | No | 10 (21.28%) | 36 (46.15%) | 0.005** |
| Yes | 37 (78.72%) | 42 (53.85%) | ||
| Histology grade | I + II | 21 (48.84%) | 36 (47.39%) | 0.878 |
| III + IV | 22 (51.16%) | 40 (52.61%) | ||
| Tumor | <3cm | 20 (47.62%) | 40 (52.63%) | 0.602 |
| >3cm | 22 (52.38%) | 36 (47.37%) | ||
aMore than 20% of cells in this subtable have expected cell counts less than 5. Chi-square results may be invalid; *The Chi-square statistic is significant at the 0.05 level; **The Chi-square statistic is significant at the 0.01 level.